SPHINGOTEC THERAPEUTICS GMBH has a total of 11 patent applications. It decreased the IP activity by 77.0%. Its first patent ever was published in 2017. It filed its patents most often in WIPO (World Intellectual Property Organization), Brazil and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are MEDIRISTA BIOTECHNOLOGIES AB, INST ETHNOMEDICINE and ST VINCENTS HOSP SYDNEY.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 2 | |
#2 | Brazil | 1 | |
#3 | Canada | 1 | |
#4 | China | 1 | |
#5 | EPO (European Patent Office) | 1 | |
#6 | Israel | 1 | |
#7 | Republic of Korea | 1 | |
#8 | Mexico | 1 | |
#9 | Singapore | 1 | |
#10 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Climate change adaptation technologies | |
#5 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Bergmann Dr Andreas | 5 |
#2 | Bergmann Andreas | 3 |
#3 | Andreas Bergmann | 2 |
Publication | Filing date | Title |
---|---|---|
BR112018071583A2 | methods for determining dpp3 and therapeutic methods |